DOI:
10.1055/s-00000104
Zentralblatt für Chirurgie
LinksClose Window
References
Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M. et al.
Efficacy and safety of the monolconal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.
Crit Care Med 2004; 32: 2173-2182
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.